HemaCare Corp. has registered 700,000 shares of common stockissuable upon exercise of the company's publicly traded warrants.Each warrant is exercisable to purchase one share of common stock(NASDAQ:HEMA) at $3.50 per share until Oct. 21, 1992. The ShermanOaks, Calif., company may redeem the warrants if the stock priceequals or exceeds $5.25 per share for at least 20 trading days withina period of 30 consecutive trading days. Shares of the developer ofhemapheresis-derived products closed down $1.75 at $8.75 onTuesday.
(c) 1997 American Health Consultants. All rights reserved.